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Abstract 
Introduction: Dentin Hypersensitivity is a frequently reported distressing oral 
condition ranging from mild to unbearable pain. Although variable, predominantly 
appears as a transitory acute pain caused by several stimuli and it cannot be attributed 
to any other dental conditions than gingival recession, tooth erosion, abrasion and/or 
abfraction. The control of symptomatology should, firstly, focus on preventive 
strategies and subsequently direct the therapy with the objective of interfering, 
transiently or permanently, on its pain mechanism. 
Objective: To evaluate the short-term effectiveness of a nano-hydroxyapatite 
(7,5%) based desensitizing dentifrice compared to a fluoridated toothpaste on the 
reduction of dentin hypersensitivity.  
Methods: This was a double blind, randomized, parallel-group, 4-week study in 
healthy adults with self-reported and clinically diagnosed dentin hypersensitivity. Thirty 
subjects with at least two eligible teeth were randomly distributed to one of the two 
experimental groups and instructed to brush twice daily with the allocated toothpaste. 
Tooth sensitivity was assessed at baseline, after 2 and 4-weeks of treatment in 
response to evaporative (air-blast) and thermal (ice) stimuli measured by visual 
analogue scale. Data collected at all evaluations was then compared using the 
Wilcoxon test and further analysis was performed with the U Mann-Whitney test and 
the Bonferroni correction.   
Results: All 30 participants completed the clinical study and the results obtained 
confirm that for both treatments there was a statistically significant reduction on dentin 
hypersensitivity throughout the 4-week observation period. No statistical or clinical 
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differences amongst the two therapies were demonstrated for the two pain 
assessments at the end of the study, with exception to the response of the evaporative 
stimuli at baseline, where there was a statistically significant difference between the 
experimental groups. 
Conclusions: The performance of the two dentifrices was similar after the 4-
week treatment time demonstrating identical benefits concerning tooth sensitivity on 
short-term basis as they both seem to be clinically capable of and effective in reducing 
dentin hypersensitivity. 
Key-words 
 “Dentin hypersensitivity”, “dentine occlusion”, “treatment dentin hypersensitivity”, 
“nano-hydroxyapatite” and “dentin sensitivity etiology” 
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Resumo 
Introdução: A Hipersensibilidade Dentinária é uma condição oral dolorosa 
comummente citada na prática clínica que varia de dor leve a insuportável. Embora 
variável, surge predominantemente como uma dor aguda de curta duração transitória 
provocada por diversos estímulos e não pode ser atribuída a outras condições 
dentárias que não a recessão gengival, erosão dentária, abrasão e/ou abfração. O 
controlo da sintomatologia deve, numa primeira fase, apostar em estratégias 
preventivas e, posteriormente, dirigir a terapia com o objetivo de interferir, transitória 
ou permanentemente, no seu mecanismo de dor. 
Objetivo: Avaliar a eficácia a curto prazo de um dentífrico dessensibilizante 
constituído por nano-hidroxiapatite (7,5%) em comparação com uma pasta dentífrica 
fluoretada (placebo) sobre a redução na hipersensibilidade dentinária.  
Metodologia: Estudo duplamente cego, randomizado, em grupo paralelo, com 
duração de 4 semanas em adultos saudáveis autodiagnosticados e confirmados 
clinicamente detentores de hipersensibilidade dentinária. Trinta indivíduos com pelos 
menos dois dentes elegíveis foram distribuídos aleatoriamente num dos dois grupos 
experimentais e instruídos a escovar duas vezes por dia com a pasta dentífrica 
selecionada. A sensibilidade foi avaliada na baseline e após 2 e 4 semanas de 
tratamento, em resposta a estímulos evaporativos (ar) e térmicos (gelo), medidos por 
uma escala visual analógica. Os dados recolhidos em todas as avaliações foram, então, 
comparados através do teste Wilcoxon tendo-se, posteriormente, recorrido ao teste U 
Mann-Whitney com a correção de Bonferroni. 
Resultados: Todos os 30 participantes completaram o estudo clínico sendo que 
os resultados obtidos confirmaram que, para ambos os tratamentos, houve uma 
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redução estatisticamente significativa da hipersensibilidade dentinária ao longo do 
período de observação de 4 semanas. Não foram demonstradas diferenças estatísticas 
ou clínicas entre as duas abordagens terapêuticas para as duas avaliações de dor no 
final do estudo, com exceção da resposta aos estímulos evaporativos na baseline, 
onde houve diferença estatisticamente significante entre os grupos experimentais. 
Conclusões: Os dois dentífricos atuaram de forma semelhante, no intervalo de 
4 semanas de tratamento, demonstrando benefícios idênticos no que concerne à 
sensibilidade dentária a curto prazo, uma vez que ambos parecem ser clinicamente 
capazes e eficazes na redução da hipersensibilidade dentinária.  
Palavras-chave 
“Hipersensibilidade dentinária”, “oclusão dentinária”, “tratamento hipersensibilidade 
dentinária”, “nano-hidroxiapatite” e “etiologia sensibilidade dentinária” 
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I. Introduction 
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Dentin Hypersensitivity (DH) is a frequently reported painful oral condition 
that affects the oral comfort and function amongst patients interfering with their 
quality of life. More often patients accept the discomfort caused by this complaint 
and commonly fail to inform and seek help. For that reason DH is also one of the 
least predictably and successfully treated chronic problem in dentistry (1-3). 
Pain arising from DH may be variable in character and intensity but it is 
usually described as a short or transient episode of sharp and well-localized pain 
which arises from exposed dentine tubules due to aetiological factors such as 
gingival recession, dental erosion, abrasion and/or abfraction in response to 
typically thermal, evaporative, mechanical/tactile, osmotic or chemical stimulation, 
and cannot be attributed to any other form of dental defect, disease or pathology (4-
6). The reported prevalence of DH differs widely and ranges from 4% to 57% in the 
general population (7-10). Therefore, in order to obtain a correct diagnosis, all other 
pathologies that may elicit the same clinical symptoms must be excluded.  
Its pathogenesis remains unclear and many hypotheses have been proposed 
to explain its biologic mechanism, however scientific evidence supports the 
Hydrodynamic Theory, postulated by Gysi in 1900 and reinforced by Brännström in 
1963 (1, 11-13). According to the principles of the hydrodynamic theory, a 
hyperesthesia results from pain-provoking stimuli when contacting exposed dentine, 
causing changes of the fluid flow inside the dentinal tubules. This activates the 
baroreceptors leading to a neural signal to the pulp and may, if certain 
physiological parameters are met, generate a pain response (3, 4, 6, 14).  
Consciousness of the patient clinical history combined with the 
understanding of the pathophysiology of DH are essential in order to better 
comprehend, prevent and evaluate the best treatment option (2). In the past, DH 
treatment has been conducted without considering the aetiological factors, 
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emphasizing the limitations of such an approach. Actually, the management of DH 
symptomatology should, firstly and ideally, consider preventive strategies, directed 
towards the aetiology, such as modification of dietary intake, oral hygiene 
technique and occlusal contacts. After this intervention it should be considered a 
direct therapy, which aims to interfere whether transiently or permanently with the 
mechanism described for this condition (5, 7). 
A vast range of treatment techniques and materials exist for managing DH 
and according to the mode of delivery can be professionally applied at the clinical 
office or at home by the patient. In its essence they all fall under two major 
categories of their mechanisms of action, nerve stabilisation/desensitisation, 
physical occlusion and/or reduction of the diameter of exposed dentinal tubules (6, 7, 
11-13, 15). In order to achieve the desired results, the agents used at home include 
dentifrices, gels and mouthwashes containing fluorides or other desensitizing 
substances such as potassium salts, formaldehyde, strontium salts, oxalates, and 
more contemporary materials such as arginine and nano-hydroxyapatite (n-HA). N-
HA is considered one of the most biocompatible and bioactive substances – its 
nano-sized particles may easily diffuse into the dentinal tubules and promote 
mineralisation – and is used in variable concentrations in several formulated 
toothpastes (1, 16). The treatment modalities used at the office include the application 
of dentin sealers such as resins, mucogingival plastic surgery and, more recently, 
the use of laser irradiation (5, 12, 13, 15). 
Currently, literature presents many clinically beneficial approaches at treating 
DH, however there has not yet been discovered a technique to be clearly superior 
to the others in managing this condition (2, 11). 
DENTIN HYPERSENSITIVITY MANAGEMENT 
A Clinical Study Investigating The Efficacy Of A Desensitizing Dentifrice  
 
 8 
This investigation intends to evaluate the short-term effectiveness of a 
dentifrice with 7,5% n-HA compared to a fluoridated toothpaste – placebo – on DH 
reduction.  
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II. Methodology 
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II.1 Study Design and Participants Recruitment 
This study consisted on a 4-week double blind, two treatment, parallel-
group, randomised clinical trial in healthy adult patients with self-reported and 
clinically diagnosed DH. Two groups were enrolled to participate in a treatment 
plan with (1) “Nano-Hydroxyapatite” based dentifrice (2) “placebo” fluoridated 
toothpaste. This study was conducted in Oporto, Portugal, at the Dental Clinic of 
the Faculty of Dental Medicine of the University of Porto after approval by the 
faculty’s ethics committee. 
II.2 Inclusion Criteria 
Table I – Inclusion Criteria  
Aged 18 and over with good oral health 
2 or more hypersensitive teeth (criteria is described in the assessment procedure) 
No systemic diseases or controlled systemic diseases (e.g. Diabetes) 
Availability and interest to collaborate for the duration of the study and to sign an informed 
consent form 
Motivated to reduce DH 
 
II.3 Exclusion Criteria 
Table II – Exclusion Criteria 
Under 18 years old 
Active caries, uncontrolled periodontal disease, untreated fungal and/or tumours oral lesions, 
extensive/defective restorations, hypersensitivity teeth with significant mobility and post-
operative hypersensitivity 
Pregnancy or lactation 
Uncontrolled systemic diseased or began medication with anticonvulsants, antihistamines, 
antidepressants, sedatives, tranquilizers, anti-inflammatory drugs or daily analgesics within one 
month prior to the start of the study or during the course of the study  
History of allergy and/or sensitivity to the test products or their ingredients 
Individuals who had participated in any other desensitizing dentifrice study or used a 
desensitized dentifrice within the last three months 
No availability to participate in the study and/or uninterested  
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II.4 Participants Selection 
Volunteered healthy patients with at least two sensitive teeth that met all the 
criteria at the screening and baseline examination performed at the FMDUP clinic 
were enrolled onto the study and were randomly allocated to a treatment group by 
the researcher so that approximately equal number of subjects received each 
treatment.   
II.5 Sample size determination 
The target group consisted of all patients that arrived to the FMDUP clinic 
complaining of teeth sensitivity. The collaboration of 5th and 4th year Dental 
Medicine Students from the FMDUP clinic was essential for the recruitment and 
selection of participants. A questionnaire (appendix 3) was applied to 113 patients, 
between January and April of 2017, in order to assess the presence of DH.  
DH was firstly diagnosed by enquiring patients to rate their perception of 
sensitivity to different trigger stimuli such as thermal, osmotic and mechanical 
stimulation. Sensitive teeth were identified by the patient’s response to air-blast 
stimulus, applied with a dental air syringe to the exposed buccal surface. 
The first 30 prospective participants who met the inclusion/exclusion criteria 
and signed an informed consent form (appendix 2) were selected. The main 
investigator assigned a baseline hypersensitivity evaluation – air-blast and thermal – 
along with an oral soft and hard tissue assessment and the patients were requested 
to answer a survey concerning the pain associated with DH (appendix 4).  
At screening, each selected participant was sequentially randomised being 
allocated with its unique screening assigned number, and then was randomly 
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appointed to one of the two study treatments: (1) toothpaste “n-HA” (2) toothpaste 
“Placebo”. Each participant could have two or more teeth selected. 
II.6 Test materials 
Both products were letter coded and distributed in similar containers in order 
to maintain the study participants and the examiner unaware of it contents. 
Test group A: N-HA based dentifrice (Fluidinova© NanoXIM•CarePaste) 
• 7,5% n-HA – to promote dentin tubules occlusion and enamel 
remineralisation. 
Table III – Composition of dentifrice used for Group A treatment 
Composition 
7,5% nanoXIM.CarePaste (1.16% n-HA) Sorbitol; Aqua; Calcium Carbonate; Hydroxyapatite; Silica; 
Sodium Laureth – 2 Sulfate; Parfum; Cellulose Gum; Titanium Dioxide; Sodium Saccharin; Triclosan 
Test group B: Control group (Placebo) 
• Toothpaste with no desensitizing agents. 
Table IV – Composition of dentifrice used for Group B treatment 
Composition 
Sorbitol; Aqua; Calcium Carbonate; Silica; Sodium Laureth – 2 Sulfate; Parfum; Cellulose Gum; 
Titanium Dioxide; Sodium Saccharin; Triclosan, 1450 ppm F 
The two treatment products were used in two sets – office and at home – and 
were all applied in the same manner. 
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II.7 Treatment procedure 
Following the assignment of the subjects into the two different study groups, 
the main investigator applied the test materials. To ensure the examiner remained 
blind, the preparation and dispersal of the blinded study treatments took place in a 
previous separate area. 
II.7.1 Application procedure in Office 
• Clean all surfaces to remove excess saliva; 
• Application of a pea sized dose of test toothpaste on the cervical 
dentin of the selected tooth with the fingertip massaging the area for 
approximately 20 timed seconds, followed by assessment (Figure 1); 
Each tooth was treated individually and sequentially. 
Figure 1 – Illustration of application procedure 
Following topical application and assessment, participants were provided 
with the same test product (toothpaste with 96 g) for use at home. 
II.7.2 Post-application instructions (appendix 6): 
• Do not eat or drink for the 30 minutes following the procedure 
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• Avoid hot drinks, products containing alcohol and sticky or chewy foods for 
at least 4 hours  
II.7.3 Application procedure at Home 
Subjects should only use the designated paste during the study. 
Each participant was educated to first brush all other areas as their normal 
oral hygiene routine and then apply the product onto the sensitive teeth and 
massage for approximately 30 seconds - subjects were instructed to brush only with 
the nominated paste for two minutes, at least twice daily for the duration of this 
study.  
The post-application instructions were the same as the in-office treatment. 
II.7.4 Additional instructions 
Subjects were advised to refrain from any other oral hygiene procedures, 
such as the use of mouthwashes, throughout the duration of the study. In addition, 
were instructed to refrain from chewing gum for eight hours and from eating and 
drinking for four hours prior to their follow-up hypersensitivity evaluations. There 
were not other restrictions regarding diet or smoking habits during the course of the 
study. 
Used toothpaste tubes were collected from participants at the end of the 
study and product use compliance evaluated by weight. In the occurrence of more 
test material being required, participants were requested to return to FMDUP clinic 
to collect additional dentifrice (Figure 2).  
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Figure 2 – Illustration of some of the collected toothpastes 
II.8 Follow-up 
Subsequent evaluations were conducted after 2 and 4 weeks of product use 
at the FMDUP clinic.  
In order to appraise the progress of the treatment, all the assessments were 
conducted in every visit – oral soft and hard tissue examination, as well as, air-blast 
and thermal response evaluations. In addition, the Dentin Hypersensitivity Survey 
(appendix 4) was given out to assess the management of this condition. The 
examiner did not hold the previous responses to the cited survey as it was kept 
secret by the researcher, so that the patient’s feedback and/or the examiner’s 
approach would not be persuaded in any way and also, to enable the comparison of 
all responses at the end of this investigation. 
II.9 Assessments 
Two outcome (pain) measures – Air-Blast and Thermal evaluations  – were 
used at enrolment, baseline visit before and after application, and at the designated 
follow-up dates. 
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II.9.1 Hypersensitivity assessments 
Air-Blast sensitivity assessment: 
• Isolation of the sensitive tooth from the adjacent teeth (mesial and distal) by 
the placement of the examiner’s fingers over the neighbouring teeth (Figure 
3); 
• Air was delivered from a standard dental unit air syringe at 60 psi (±5 psi) and 
19 °C (±5 °C) directly at the exposed buccal surface for 3 seconds and from a 
distance of approximately 1 cm (Figure 4); 
• Two response measures were taken, a subjective assessment utilising a visual 
analogue scale (VAS) (Figure 5) and an examiner-based Schiff assessment. 
 
 Figure 3 – Illustration of air-blast assessment procedure 
 
Figure 4 – Illustration of air-blast assessment procedure (distance of approx. 1 cm.) 
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VAS 
Subjects were asked to rate the intensity of their response to the stimulus 
from no pain to intolerable pain. 
 
 
 
 
 
Figure 5 – Visual Analogue Scale 
 
Schiff Cold Air Sensitivity Scale (SCASS) 
0 – Subject does not respond to air stimulus 
1 – Subject responds to air stimulus, but does not request discontinuation of 
stimulus 
2 – Subject responds to air stimulus and requests discontinuation or moves from 
stimulus 
3 – Subject responds to air stimulus, considers stimulus to be painful and requests 
discontinuation of the stimulus 
Subjects with scores of 2 or 3 present and measured at the baseline 
examination were included in this study. 
Thermal sensitivity was assessed in the following manner: 
• Application of ice-cold water to the exposed dentin surface while adjacent 
teeth were isolated during testing using cotton rolls (Figure 6). 
• Sensitivity was measured using a VAS (Figure 5). Subjects were asked to rate 
the intensity of their response to the stimulus from no pain to intolerable 
pain.  
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderada Severa Intolerável 
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Figure 6 – Illustration of thermal assessment procedure 
Subjects with scores greater than 5 present and measured at the baseline 
examination were included in this study. 
If both baseline scores – air-blast and thermal – were met by the participant it 
would verify its eligibility hence the individual would be qualified for participation.  
II.9.2 Clinical Assessment 
To determine eligibility, oral soft and hard tissue examinations were 
performed in all participants, in order to verify if any of the exclusion criteria was 
present, such as dental mobility. 
The examiner assessed the oral cavity and peri-oral area using a dental light 
and mirror. This examination included an evaluation of the soft and hard palate, 
gingival mucosa, buccal mucosa, mucogingival fold areas, tongue, sublingual and 
submandibular areas, salivary glands and the tonsilar and pharyngeal areas.  
All assessments were performed by the same examiner and conducted at 
enrolment, baseline and designated follow-up dates. 
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II.10 Adverse Events 
 The main investigator interviewed, in every visit, the subjects in order to 
acquire any report of adverse events (AEs) and the use of concomitant medications.  
All observed or subject-reported AEs, regardless of treatment group, were 
recorded. AEs were monitored from the time that the subject provided informed 
consent, which was prior its participation in this study, up to including 7 days after 
the last administration of the investigational product. 
II.11 Statistical Analysis  
Results were recorded and subjected to statistical analysis. Intending to 
depict de study sample, descriptive analysis was performed in which quantitative 
data was described by the calculation of the mean and standard deviation (SD) and 
qualitative variables were compared using the Chi-Square analysis. 
In regard to the efficacy evaluation, the non-parametric Friedman test was 
performed to compare the raw means of air-blast and thermal hypersensitivity 
scores of the two different regiments at baseline, 2 and 4 weeks of product use. The 
results were then compared using the Wilcoxon and the U Mann-Whitney tests 
considering, simultaneously, the Bonferroni correction.  
In order to perform the data analysis the software utilized to register all the 
collected data was the Microsoft® Excel® for Mac (2011 Version 14.7.3, 2010 
©Microsoft Corporation, Redmond, Washington, USA), and for the statistical 
analysis the SPSS® (Statistical Package for the Social Science, IBM SPSS Statistics for 
Macintosh Version 24.0. Armonk, NY: IBM Corp.) employing the statistical 
significance set at α=0,05 for all tests.  
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III. Results 
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III.1 Subject Demographic and Baseline Characteristics  
 A total of 113 subjects were interviewed between January and April, in order 
to assess for eligibility to participate in the trial, of whom 30 met the necessary 
inclusion/exclusion criteria and were randomly assigned to the two study groups. All 
subjects complied with the protocol and completed the 4-week clinical study. An 
outline of the progression of the clinical trial is shown in Figure 7.  
Figure 7 – Flowchart of participants throughout each stage of the study 
A	 B	
Enrollment	
Assessed	for	eligibility	
(n	=	113)	
Excluded	(n	=	83)	
• Not	meeting	inclusion	
criteria	(n	=	71)	
• Declined	to	participate	
(n	=	12)	
• Other	reasons	(n	=	0)	
Randomized	(n	=	30)	
Allocated	to	intervention	(n	=	13)	
• Received	allocated	intervention	
(n	=	13)	 	
• Did	not	received	allocated	
intervention	(n	=	0)		
Allocation
Follow-up	
Analysis	
Allocated	to	intervention	(n	=	17)	
• Received	allocated	intervention	
(n	=	17)	 	
• Did	not	received	allocated	
intervention	(n	=	0)		
Lost	to	follow-up	(n	=	0)		 	
Discontinued	 intervention	 (n	 =	 0)
	 	
Lost	to	follow-up	(n	=	0)		 	
Discontinued	 intervention	 (n	 =	 0)
	 	
Analysed	(n	=	13)	 	 	
• Excluded	from	analysis	(n	=	0)
	 	
Analysed	(n	=	17)	 	 	
• Excluded	from	analysis	(n	=	0)
	 	
Baseline	Sensitivity	
Examination		
(air-blast	and	thermal)	
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The study entailed 30 individuals, 13 (43,3%) enrolled on group A and 17 
(56,7%) on group B. All study participants were Caucasian between 21 and 70 years 
old (mean age 31.66 ± 13.24 years) and it involved 5 males (16,7%) and 25 females 
(83,3%). The age group the highest occurrence of DH was the 18-24 years old 
(Figure 8). The treatment groups did not differ significantly with respect either to 
age (p> 0,284) or to gender (p> 0,070).  
Figure 8 – Presence of DH in the age groups studied 
An evaluation of different characteristics of all individuals was carried out, 
and the summary of the demographic and baseline characteristics of all subjects by 
treatment is shown in Table V.  
Concerning smoking habits, 26,7% (n=8) of the sample population were 
smokers and 23,3% (n=7) relate to female participants (Figure 9). There is no 
statistically significant difference between gender and smoking habits according to 
Pearson Chi-Square significance (p> 0,419). 
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Figure 9 – Smoking Habits 
 
 Considering oral hygiene habits, 96,7% (n=29) of the patients reported 
brushing their teeth more than once a day, while only 3,3% (n=1) brushes once or 
less a day. Individuals were also asked what type of toothbrush bristles utilize, and 
70% (n=20) affirmed the use of medium bristles, while 8 participants (26,7%) have 
soft or extra-soft options and only 1 participant (3,3%) uses a toothbrush featuring 
hard/firm bristles (Figure 10). There is no statistically significant difference between 
both oral hygiene habits and the two study groups  (A and B) according to Pearson 
Chi-Square significance (p> 0,334). 
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Figure 10 – Type of bristles used among participants 
Regarding the use of complementary methods to improve oral hygiene, 25 
individuals (83,3%) affirmed having the regular use of dental floss/interdental 
brushes, while 16,7% (n=5) do not use any other technique other than brushing. 
Taking a look at both study groups, 76,5% (n=13) of the participants from group B 
and 92,3% (n=12) from group A have this practice as part of their oral hygiene 
routine (Figure 11). 
 Figure 11 – Flossing Habits 
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Regarding DH characteristics such as self-reported history by the individual 
and trigger stimuli, it was established that there is a higher prevalence of pain 
response to cold stimuli 83,3% (n=25), followed by osmotic – sweet and/or acidic 
stimuli – 33,3% (n=10), then dental brushing and masticatory pressure/tension with 
13,3% (n=4) and hot stimuli with 10% (n=3). On DH antecedents, 5 participants 
(16,7%) affirmed having symptoms for less than 1 year while the remaining 25 
(83,3%) have symptomatology for longer than a year.   
In addition, it was found that in the study sample of 30 participants, there is 
gingival recession in 63,3% (n=19) of the cases (Figure 12).  
 Figure 12 – Prevalence of gingival recession 
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The vast majority of respondents (70%) referred feeling sensitivity at times, 
while only 26,7% (n=8) and 3,3% (n=1) reported having pain frequently and 
permanently, respectively (Figure 13).  
 Figure 13 – Frequency of pain 
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Table V – Demographic and baseline characteristics by treatment group for all subjects 
Characteristic 
Test group A 
(n=13) 
Test group B 
(n=17) 
Total 
(n=30) 
Age (years)a 
Mean 33.77 34.06 31.66 
SD 15.74 14.10 13.24 
Median 24.00 26.00 25.00 
Range 22-70 21-68 21-70 
Sex, n (%)a 
Male  4 (30.8) 1 (5.9) 16.7 
Female  9 (69.2) 16 (94.1) 83.3 
Smoker, n (%) 
Yes 3 (23.1) 12 (70.6) 22 (73.3) 
No 10 (76.9) 5 (29.4) 8 (26.7) 
Hygiene Habits, n (%) 
Brushes <1 0 (0) 1 (5.9) 1 (3.3) 
Brushes >1 13 (100) 16 (94.1) 29 (96.7) 
Dental Floss 
Yes 3 (23.1) 5 (29.4) 8 (26.7) 
No 10 (76.9) 12 (70.6) 22 (73.3) 
Bristles, n (%) 
Soft 5 (38.5) 3 (17.6) 8 (26.7) 
Medium 8 (61.5) 13 (76.5) 21 (70) 
Hard 0 (0) 1 (5.9) 1 (3.3) 
History of DH, n (%) 
<1 year 1 (7.7) 4 (23.5) 5 (16.7) 
>1 year 12 (92.3) 13 (76.5) 25 (83.3) 
Trigger stimuli, n (%) 
Thermal 9 (69.2) 9 (52.9) 18 (60) 
Mechanical 0 (0) 0 (0) 0 (0) 
Osmotic 1 (7.7) 0 (0) 1 (3.3) 
Various 3 (23.1) 8 (47.1) 11 (36.7) 
SD, standard deviation 
a No statistically significant difference was indicated between the two treatment groups 
with respect to either gender or age (p > 0,05) 
 
 
The sample involved 184 teeth in total (76 in group A and 108 in group B), 
and consisted of 59,8% incisors, 14,2% canines, 19% premolars and 7% molars. 
Table VI depicts the type of teeth included in the study.  
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Table VI – Teeth included in the study 
Type of teetha 
Test group Aa 
(n=13) 
Test group Ba 
(n=17) 
Total 
(n=30) 
Upper incisor, n (%) 12 (15.8) 25 (23.1)  37 (20.1) 
Lower incisors, n (%) 29 (38.2) 44 (40.7) 73 (39.7) 
Upper canines, n (%) 4 (5.3) 9 (8.3) 13 (7.1) 
Lower canines, n (%) 5 (6.6) 8 (7.4) 13 (7.1) 
Upper premolars, n (%) 13 (17.1) 8 (7.4) 21 (11.4) 
Lower premolars, n (%) 5 (6.6) 9 (8.3) 14 (7.6) 
Upper molars, n (%) 6 (7.9) 3 (2.8) 9 (4.9) 
Lower molars, n (%) 2 (2.6) 2 (1.9) 4 (2.1) 
a No statistically significant difference was indicated between the two treatment groups with 
respect to type of teeth included in the study (p > 0,05) 
 
 
The teeth included fall within a range of 2 to 8 and on average each 
participant had 3.99 ± 1.98 teeth included in the clinical trial. 
A brief analysis of the association between the pain intensity – gentle, 
moderate and severe – and past history of DH reported by the participant was 
carried out. It is observed no statistically significant difference (p>0,738). Analysing 
the results, summarised in Table VII, we may conclude that 16,7% of the participants 
in this sample experience symptomatology for more than a year and only a small 
proportion of the studied population (6,7%) suffers from severe pain.  
Table VII – Association between Pain Intensity and DH History 
Pain Intensity  
How long suffer from DH  
Total 
<6 months >6 months >1 year 
Gentle 2 9 2 13 
Moderate 3 10 2 15 
Severe 0 1 1 2 
Total 5 20 5 30 
No statistically significant difference (p > 0,05) 
 
 
The association of DH and gender, was also analysed and it was found a 
statistically significant relationship (p<0,008) between those variables. 
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III.2 Intervention Analysis 
III.2.1 Efficacy Results  
In total 184 teeth were screened and the subjects responses of each 
individual tooth to air-blast and thermal assessments were measured and recorded 
at baseline, 2-week and 4-week examinations. The results (median values) are shown 
in Tables VIII.  
Table VIII – Within-group comparison of dentine hypersensitivity scores to the two stimuli tests at the 
three different intervals measured  
Treatment 
Group (n)   
Baseline 
Air-Blast 
Baseline 
Thermal 
2 weeks 
Air-Blast 
2 weeks 
Thermal 
4 weeks 
Air-Blast 
4 weeks 
Thermal 
Group A (n=76)        
Median 
Percentiles 
 5.00 6.00 3.00 5.00 3.00 4.00 
25 3.00 4.00 1.00 4.00 2.00 3.00 
  50 5.00 6.00 3.00 5.00 3.00 4.00 
  75 7.00 8.00 4.00 8.00 4.00 7.00 
Group B (n=108)        
Median  3.00 6.00 4.00 6.00 2.00 4.50 
Percentiles 25 2.00 5.00 2.00 3.00 1.00 2.00 
  50 3.00 6.00 4.00 6.00 2.00 4.50 
  75 7.00 8.00 6.00 8.00 4.00 7.00 
Analysing the scores obtained from group A participants, it can be verified 
that on the baseline evaluation 50% of the participants scored pain up to the value 
of 5.00 and 6.00 for the evaporative and thermal stimuli, respectively. While group 
B subjects scored lower on the air-blast evaluation, up to 3.00, but noted the same 
results on the thermal test. 
Concerning the results on the 2-week follow-up, from the participants of 
group B it is observed that the median value recorded for the air-blast evaluation 
increased slightly from a value of 3.00 to 4.00. However, it appears to be a 
reduction for the remaining values, for group A and B. 
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Regarding the last evaluation performed after 4 weeks, 75% of the 
participants from group A logged scores up to 4.00 and 7.00 on the air-blast and 
thermal stimuli, respectively. Similar results have been shown for group B subjects. 
Overall, it is observed a reduction in DH scores from baseline to the 
subsequent follow-up for the two groups, also observed on tables IX and X. 
Table IX – Pain Frequency during the 4-weeks treatment for Group A 
Pain 
Score 
Baseline 
Air-Blast  
n (%) 
Baseline 
Thermal 
n (%) 
2 weeks 
Air-Blast 
n (%) 
2 weeks 
Thermal 
n (%) 
4 weeks 
Air-Blast 
n (%) 
4 weeks 
Thermal 
n (%) 
0 1 (1.3) 1 (1.3) 9 (11,8) 1 (1,3) 4 (5,3) 3 (3,9) 
1 2 (2.6) 1 (1.3) 11 (14,5) 6 (7,9) 11 (14,5) 6 (7,9) 
2 1 (1.3) 2 (2.6) 5 (6,6) 1 (1,3) 11 (14,5) 5 (6,6) 
3 16 (21.1) 1 (1.3) 29 (38,2) 8 (10,5) 26 (34,2) 12 (15,8) 
4 14 (18.4) 16 (21.1) 6 (7,9) 15 (19,7) 10 (13,2) 18 (23,7) 
5 7 (9.2) 4 (5.3) 6 (7,9) 10 (13,2) 6 (7,9) 7 (9,2) 
6 13 (17.1) 20 (26.3) 3 (3,9) 3 (3,9) 0 (0) 5 (6,6) 
7 4 (5.3) 8 (10.5) 0 (0) 6 (7,9) 1 (1,3) 3 (3,9) 
8 6 (7.9) 8 (10.5) 3 (3,9) 11 (14,5) 3 (3,9) 4 (5,3) 
9 7 (9.2) 5 (6.6) 0 (0) 5 (6,6) 0 (0) 6 (7,9) 
10 5 (6.6) 10 (13.2) 4 (5,3) 10 (13,2) 4 (5,3) 7 (9,2) 
Total 76 (100) 
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Table X – Pain Frequency during the 4-weeks treatment for Group B 
Pain 
Score 
Baseline 
Air-Blast  
n (%) 
Baseline 
Thermal 
n (%) 
2 weeks 
Air-Blast 
n (%) 
2 weeks 
Thermal 
n (%) 
4 weeks 
Air-Blast 
n (%) 
4 weeks 
Thermal 
n (%) 
0 7 (6.5) 7 (6.5) 12 (11,1) 0 (0) 21 (19,4) 5 (4,6) 
1 4 (3.7) 0 (0) 12 (11,1) 2 (1,9) 14 (13,0) 8 (7,4) 
2 17 (15.7) 1 (0.9) 22 (20,4) 19 (17,6) 27 (25,0) 19 (17,6) 
3 29 (26,9) 6 (5.6) 3 (2,8) 17 (15,7) 10 (9,3) 7 (6,5) 
4 3 (2.8) 9 (8.3) 10 (9,3) 7 (6,5) 10 (9,3) 15 (13,9) 
5 0 (0) 23 (21.3) 12 (11,1) 6 (5,6) 13 (12,0) 11 (10,2) 
6 18 (16.7) 13 (12) 13 (12,0) 8 (7,4) 4 (3,7) 10 (9,3) 
7 5 (4.6) 5 (4.6) 8 (7,4) 20 (18,5) 3 (2,8) 15 (13,9) 
8 21 (19.4) 23 (21.3) 13 (12,0) 14 (13,0) 6 (5,6) 12 (11,1) 
9 0 (0) 15 (13.9) 3 (2,8) 14 (13,0) 0 (0) 5 (4,6) 
10 4 (3.7) 6 (5.6) 0 (0) 1 (0,9) 0 (0) 1 (0,9) 
Total 108 (100) 
 
III.2.2 Comparison Results Within Study Groups 
The non-parametric Friedman test was performed to compare within 
experimental groups and the time intervals studied. The results are shown on Table 
XI. 
At first, the results from the two groups were analysed individually. For both 
groups, there is a statistically significant reduction (p<0,0005) in DH scores from 
baseline to subsequent follow-up examinations. 
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Table XI – Intra-group comparison of raw means throughout the 4-weeks treatment 
Evaluations 
Group A  
(n=76) 
Group B 
(n=108) 
Air-blasta 
Baseline 2.62 2.47 
2-weeks 1.64 2.06 
4-weeks 1.74 1.47 
aStatistically significant difference (p <0,0005) 
Thermala 
Baseline 2.18 2.46 
2-weeks 2.12 2.05 
4-weeks 1.70 1.49 
aStatistically significant difference (p <0,0005) 
 
The Wilcoxon test was then applied in order to further analyse the results 
(Tables XII, XIII and XIV). 
Table XII – Intra-group comparison of the variation of responses throughout the time intervals established 
Evaluations    
Air-Blast 
 Negative Ranksa Positive Ranksb Tiesc 
 A B A B A B 
Baseline vs. 2 weeks 50 57 5 22 21 29 
Baseline vs. 4 weeks 53 76 4 9 19 23 
2 weeks vs. 4 weeks 15 52 24 5 37 51 
Thermal 
 Negative Ranksa Positive Ranksb Tiesc 
 A B A B A B 
Baseline vs. 2 weeks 28 63 25 27 23 18 
Baseline vs. 4 weeks 38 79 13 15 25 14 
2 weeks vs. 4 weeks 35 54 14 8 27 46 
a Hypersensitivity reduction in relation to the baseline values  
b Hypersensitivity increase in relation to the baseline values  
c Hypersensitivity maintenance in relation to the baseline values  
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Table XII corresponds to the differences in DH values of examinations at 2 
and 4 weeks compared to baseline results, as well as the second evaluation 
compared to the final follow-up. The results obtained for negative ranks means the 
reduction of pain sensitivity whereas the positive ranks account for an increased 
sensitivity score to painful stimuli. When differences in DH scores did not occur, it 
was perceived as an indicator of no variation in pain. Both groups showed 
decreased levels of sensitivity for the duration of the clinical study. 
Table XIII – Within-group changes for the time intervals established - Group A 
 
According to the results illustrated on table XIII concerning the participants 
of group A, significant differences were observed from baseline scores to the air-
blast assessment for the two following revaluations. However, there is not a 
significant reduction from the 2-week to the 4-week of product use.  
For the thermal stimuli scores, there was not a significant reduction in 
sensitivity values on the first two weeks of product use nonetheless a significant 
desensitizer effect was noticed for the following evaluation. 
Evaluations    
Air-Blast 
 Z Asymp. Sig (1-tailed) p-value*
 
Baseline vs. 2 weeks -5,968 0,00025 0,00075 
Baseline vs. 4 weeks -6,105 0,00025 0,00075 
2 weeks vs. 4 weeks -0,949 0,1715 0,5145 
Thermal 
 Z Asymp. Sig (1-tailed) p-value* 
Baseline vs. 2 weeks -1,255 0,1045 0,3135 
Baseline vs. 4 weeks -4,033 0,00025 0,00075 
2 weeks vs. 4 weeks -3,538 0,00025 0,00075 
* Bonferroni adjustment based upon the three comparisons  
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Table XIV – Within-group changes for the time intervals established - Group B 
Evaluations    
Air-Blast 
 Z Asymp. Sig (1-tailed) p-value*
 
Baseline vs. 2 weeks -2,646 0,004 0,012 
Baseline vs. 4 weeks -6,417 0,00025 0,00075 
2 weeks vs. 4 weeks -5,787 0,00025 0,00075 
Thermal 
 Z Asymp. Sig (1-tailed) p-value* 
Baseline vs. 2 weeks -3,253 0,0005 0,0015 
Baseline vs. 4 weeks -5,723 0,00025 0,00075 
2 weeks vs. 4 weeks -5,089 0,00025 0,00075 
* Bonferroni adjustment based upon the three comparisons  
 
Participants from group B exhibited a statistically significant improvement for 
both air-blast and thermal stimuli scores in all evaluations, as depicted on table XIV.  
 
III.2.3 Comparison Results Between Study Groups 
To assess the efficacy of the two different dentifrices and compare its 
performance, the U Mann-Whitney test was applied (Table XV).  
On the evaluation performed at baseline the two groups were evenly 
balanced with no statistically significant differences for the thermal values obtained, 
however it is noticed a statistically significant difference with respect to the air-blast 
assessment.  
The following evaluations resulted in no statistically significant differences 
between the two test groups.  
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Table XV – Inter-group comparisons for air-blast and thermal scores 
Air-Blast 
 Z Asymp. Sig (2-tailed)  
Baseline  -2,545 0,011  
 Z Asymp. Sig (1-tailed) p-value* 
2 weeks  -1,772 0,038 0,114 
4 weeks  -1.906 0,0285 0,0855 
Thermal 
 Z Asymp. Sig (2-tailed)  
Baseline  -0,099 0,921  
 Z Asymp. Sig (1-tailed) p-value* 
2 weeks  -0.996 0,1595 0,4785 
4 weeks  -0,755 0,3775 1,1325 
* Bonferroni adjustment based upon the three comparisons  
 
III.3 Adverse Events reported 
Five participants reported five AEs during the study. All were associated with 
the Group-A dentifrice and were of very mild severity oral events (dysgeusia and/or 
tingling tongue in all five cases). No serious AEs, incidents or oral soft tissue 
abnormalities were observed. 
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IV. Discussion 
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The option for this study’s theme was based on the fact that, despite being 
considerably prevalent in today’s society, DH is not seen as a pathology but 
considered as a condition to which the individual is attached to. Even though the 
number of patients suffering from DH is high and increasing, the dental clinicians 
continue to demonstrate lack of knowledge regarding aetiology and 
pathophysiology which prevents them to provide the most adequate treatment, 
acting recurrently based on unawareness. Knowing that DH is predominantly caused 
by intraoral causes as well as influenced by oral environment – acidic conditions –, 
the dentist attains a central role in the prevention and treatment of this pathology 
capable of causing social and psychological consequences to the individuals. 
Numerous strategies have been developed for the treatment of DH. Some 
emphasize the employment of active DH management, which entails the application 
of desensitizing dentifrices, which are recommended as the initial therapy approach 
and in most cases, considered the most appropriate method. In the most severe 
cases is recommended a complete DH management, consisting of at-home and in-
office therapies (2, 5, 7, 11). One must stress that of all the proposed treatments, none 
has been proven to be the ultimate or the permanent cure for DH. 
All treatment options fall into two types of action mechanisms. The first 
involves the blockage of the nerve transmission to the pulp – nerve 
stabilisation/desensitisation –, and the second method concerns the physical 
occlusion and/or reduction of the diameter of the exposed dentinal tubules (6, 7, 11-13, 
15). Dentinal occlusion may be achieved by two different means, either by the 
deposition of an occluding layer on top of the dentine or the infiltration of the 
occluding material into the dentinal tubules – plugs. Insoluble salts usually form a 
thin aggregate on the dentine and as a result, these therapies are more effective in 
the reduction of DH than in the formation of a precipitate with the purpose of 
tubules occlusion (1, 9, 17, 18).  
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Dentifrices are an excellent mean of delivery of desensitizing particles of 
which n-HA stands out as one of the most biocompatible and bioactive materials, 
introduced to stimulate intratubular mineralisation (1, 16). Appropriately, the objective 
of this randomized clinical study was to evaluate the effectiveness of n-HA based 
dentifrice on reducing DH after a 4-week period, compared to standard fluoridated 
toothpaste.  
The prevalence acquired among the patients selected was 37.2% (n=42). 
Even though this value is lower than predicted, possibly due to a small sample – not 
all patients attending appointments at the Faculty’s clinic were interviewed 
therefore were not included in the statistics –, it is inside the prevalence range 
found in the literature, which corresponds to 4-57% (8-11). Another explanation could 
be the fact that DH is stimulated and consequently patients tend to develop an 
adaptive behaviour as they eventually try to avoid certain stimuli. Regardless this 
estimation is of little scientific value and cannot be inferred to the population. 
From the analysis of the sociodemographic variables of the interviewed 
population (n=113), it was found a statistically significant relationship between the 
variables DH and gender, supporting the hypotheses that female individuals have a 
higher likelihood of experiencing DH, which supports previous studies (12, 19-23). It is 
noteworthy that the result obtained may lie on the fact that a greater number of 
female patients have been approached regarding the symptomatology of DH 
however there may actually be statistical differences in the prevalence of DH 
depending on gender as the aetiological factors in each gender present variability 
and can lead to divergent patters of some predisposing factors such as tooth 
erosion (5). 
The presence of comorbidities is quite frequent (35.4%) specially in the older 
population and, for that reason, participants with uncontrolled systemic illnesses 
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and/or individuals that began a sort of medication within one month prior to the 
start of the study or during the course of the study were excluded as this medication 
can affect pain perception and skew the results. 
The age range included in this study is extensive, 21-70 years old. 
Nonetheless the age group most associated with DH was between 18-24 years old. 
This may be related with the context of the sample as most volunteers were within 
younger age groups. It could also be associated with the fact that youngsters are 
the target patients for specific dental treatments, such as teeth whitening as well as 
the fact that DH symptomatology has the tendency to diminish with age 
progression due to phenomena such as continuous deposition of dentine – 
secondary and tertiary – which cause obliteration of dentinal tubules and also pulp 
atrophy (23). This finding, however, does not agree with other studies that affirm a 
higher prevalence in the age group of 35-49 years old (17, 19, 23). 
According to the data obtained in the present study, the most DH affected 
teeth verified are the lower incisors (39.7%), followed by the upper incisors (20.1%) 
and upper premolars (11.4%). Kumari M., et al., 2013 (10), Mehta D., et al., 2014 (20) 
and Freitas S., et al., 2014 (24) established a higher frequency of DH on upper 
canines (12.5%) and lower premolars (11.1%). However, there is a wide discrepancy 
of results in the prevalence of affected teeth, which may be due to different causes, 
such as the presence of predisposing factors – age, history of dental treatments – or 
due to different evaluation methods. 
Concerning smoking habits, only 26.7% of the sample population were 
smokers and 23.3% relate to female participants. Once more, this result 3may 
reflect the higher number of female patients that have been interviewed. In the 
Sharma D, et al., 2013 (25) study, most subjects were non-smokers supporting the 
findings in the present study. On the contrary, Costa R., et al., 2014 (23) suggested a 
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higher association between smokers and a greater number of teeth affected with 
DH, considering this variable as a risk indicator. The contradictory findings may be 
due to the lack of research assessing the effect smoking behaviour may have on DH. 
Considering oral hygiene habits, 86.7% of the patients reported brushing 
their teeth more than once daily, as well as the vast majority (70%) revealed the use 
of medium bristles. These results show no statistically significant difference between 
the two variables and the incidence of DH, therefore there is no indication these 
characteristics may lead to a higher risk of having DH. 
Gingival recession was found in 63.3% of the sample population, result 
corroborated by different studies that presented this condition as the enabler to 
dentine exposure and one of the strongest risk indicators of DH (1, 23).  
Concerning the questions posed to the interviewed individuals, for instance, 
on oral hygiene and smoking habits, one can raise the problem of veracity and 
accuracy of responses by the constraints of the respondents. 
Aiming to compare the ability to reduce or relief pain of DH over a brief 
period of time, the present clinical study has proven that the two regiments tested 
were effective in reducing DH as both achieved similar improvements in the short-
term observation, albeit only few participants reported the complete absence of 
pain. Intra-group improvements in pain relief were demonstrated by reductions 
across all clinical evaluations scores over the designated intervals, for both groups. 
In almost all instances the changes detected within each group were towards the 
management and/or pain alleviation. 
Taking a look at the baseline values, it is perceptible that Group A had 
slightly higher scores for the evaporative evaluation, which have proven to be 
significantly different (p<0,05), as it is demonstrated on table XV, averting the 
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comparison between groups on these assessment. This evidence may also raise the 
question about the effectiveness of the randomization process and/or suggest a 
recruitment bias. Nevertheless, pondering on the fact that the non-parametric test 
used – U Mann-Whitney – is designed for small samples might explain the outcome 
acquired. 
The analyses of inter-group efficacy between the two treatment options was 
considered of primary interest in order to attempt to determine superiority of one 
dentifrice over another over time. In this study, however, those results were not 
obtained. 
The unexpected efficacy of the placebo group (B) – negative control – may 
result from two plausible reasons. First, due to the subjectivity of pain, the placebo 
effect produces an effect on clinical studies as it influences the individuals’ pain 
response, possibly due to complex psychological and physiologic interactions (15, 16, 
21), and may contribute to unforeseen and conflicting findings. Subsequently, we 
should acknowledge that the effect evaluated is cumulative, hence the participants 
compliance is required. Cofounding factors such as dietary habits – consumption of 
acidic beverages – and traumatic brushing techniques should be diagnosed during 
anamnesis and altered during the investigation to enhance the therapeutic 
approach. 
Certain studies reported no differences between regular fluoridated 
toothpastes and active-ingredients desensitizing dentifrices (1, 26, 27). The ability to 
form insoluble precipitates that may occlude the dentinal tubules (16, 24) accounts for 
the recommendation of fluoride as one of the substance to be used for the 
management of DH and may explain the efficacy on pain relief in the experimental 
group B. 
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Evaluation of the therapy options for DH is a demanding task, since both 
placebo effect and the biological desensitization over time may cofound or concur 
with the clinical results. Also, it is necessary to assume pain as a highly subjective 
matter and, consequently, difficult to quantify, and because of the imprecision 
inherent to this method of measurement two well-recognized stimuli assessments 
were performed rating tooth sensitivity in a numerical VAS of pain as its validity and 
reliability have been demonstrated for experimental and clinical trials and it is easy 
to apply and comprehend (28, 29). 
The type of stimulus can influence the painful response thereby the applied 
tests were from the least distressing – air-blast – to the most painful – thermal. In 
order to minimize interactions within stimuli an adequate period of time – approx. 
five minutes (30, 31) – between applications should be respected, which in some 
occasions was not complied and might have skewed the results. 
Although most of the results are corroborated by the literature there are a 
few weaknesses presented in this clinical study worth discussing. Firstly, the main 
investigator was the only examiner collecting the clinical data. Despite the reported 
positive results over the 4-week interval, more studies are required to help to 
determine the effect in the long term, not disregarding the variables that might 
affect the outcome, as from dietary habits and brushing technique that should be 
monitored. Also, because the study sample was considered relatively small, one 
may hypothesized that the statistical power was insufficient to produce acceptable 
results to infer conclusions to the general population.  
There has been constant innovation of the therapeutics towards achieving 
greater efficacy. They aim to increase the comfort and satisfaction in the long term, 
enabling a better quality of life for the patients. The professional approach to the 
treatment of DH should always be attentive of the etiologic and existing 
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predisposing factors, and is up to the clinical to be observant of the various 
pathologies that may be associated with the symptomatology of DH, in order to 
diagnose, intervene with the most appropriate therapy and, if possible, avoid the 
development of this condition through essential care. It is also extremely important 
to inform and demystify all acquired concepts concerning DH to the general dental 
clinics and the patients making both conscientious of the importance of this 
depreciative condition. 
Having served as a pilot study, the limitations mentioned throughout this 
discussion should be controlled in an upcoming study. With the adequate changes 
in the research protocol, this can and should be applied on a large scale, as it will 
certainly provide more valuable and reliable information. 
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V. Conclusion 
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Under these experimental conditions and within the limitations of the present 
study, it was concluded that the prevalence of DH among the sample selected was 
found within the range described in the literature, female individuals are more likely 
to experience DH than males and the age group most affected is between 18 and 
24 years old. Several stimuli may trigger a painful response, tough the cold stimuli is 
the most commonly reported amongst the present study’s individuals. Furthermore, 
the most affected teeth registered were the incisors followed by the upper 
premolars and more than 63% of the subjects presented gingival recession. 
Considering various characteristics, such as smoking and oral hygiene habits, 
no association could be established. Consequently, those features cannot be 
implicated as higher risk indicators for the manifestation of DH. 
Both investigated treatments have promising desensitizing potential based 
on the different described mechanisms of action. When compared among them, in 
the time intervals established, all proven to be equally effective and clinical 
significant superiority of one toothpaste over the other was not proven. Therefore, it 
is reasonable to conclude that both dentifrices are clinically comparable and 
efficient for the management and reduction of DH. 
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Monografia de Investigação do Mestrado Integrado em Medicina Dentária 
Faculdade de Medicina Dentária da Universidade do Porto 
Ano Letivo: 2016/2017 
 
PROJETO DE INVESTIGAÇÃO 
 
 Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
EXPLICAÇÃO DO ESTUDO 
 
Investigadora Principal: Raquel Sofia Brandão de Carvalho, Estudante MIMD 
raquelsbcarvalho@gmail.com 
 
Orientador: Professor Doutor Paulo Rui Galrão Ribeiro de Melo, 
Professor Associado da Faculdade de Medicina Dentária da Universidade do Porto  
 
Objetivos da investigação: 
 Convidamo-lo(a) a participar neste estudo “Controlo da Hipersensibilidade 
Dentinária: Estudo clínico a investigar a eficácia de um dentífrico dessensibilizante” 
como voluntário(a) e sem compensação monetária. 
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Este projeto de investigação tem como objetivo avaliar a eficácia de uma 
pasta dentífrica à base de Nano-Hidroxiapatite na redução da Hipersensibilidade 
Dentinária. 
Metodologia: 
 Numa primeira fase do projeto, será distribuído um questionário aos 
pacientes da Faculdade de Medicina Dentária da Universidade do Porto. 
Finda esta primeira etapa, os primeiros 50 potenciais participantes que 
satisfaçam os critérios de inclusão/exclusão e assinem o consentimento informado 
serão elegidos para participar no estudo supracitado. Neste seguimento, será 
realizado exame clínico às peças dentárias, aos tecidos moles e duros e, será 
solicitado o preenchimento de um questionário que diz respeito à dor associada à 
Hipersensibilidade Dentinária. 
Os participantes deste estudo serão divididos por dois grupos. 
Grupo A: administração de dentífrico à base de Nano-Hidroxiapatite 
Grupo B: grupo de controlo 
Posteriormente, serão agendadas avaliações/aplicações 2, 4, 6 e 8 semanas 
após o uso de produto, que serão efetuadas por um examinador clínico diferente. 
Resultados/Benefícios esperados: 
 Esta investigação intende informar os pacientes dos diversos tratamentos 
disponíveis, como prevenir o aparecimento de novas alterações e diminuir a 
evolução das complicações existentes e, ainda, consciencializar para a importância 
da saúde oral e do acompanhamento frequente pelo Médico Dentista. 
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Riscos/desconforto: 
 No que respeita aos riscos associados o presente estudo clínico não prevê 
qualquer risco/desconforto para os seus participantes. O possível desconforto será 
o inerente ao preenchimento de um questionário e ao exame clínico seguido da 
aplicação do produto. 
Características éticas: 
 A realização deste estudo clínico está sujeita ao preenchimento de 
consentimento informado pelo participante. Caberá à investigadora principal 
esclarecer qualquer dúvida, referindo o âmbito do trabalho do estudo. O 
participante pode aceitar ou recusar participar no presente estudo clínico e revogar 
o consentimento de participar a qualquer momento. A confidencialidade dos dados 
e o anonimato dos participantes encontra-se assegurada. Esta investigação não tem 
quaisquer fins financeiros ou económicos, sendo meramente académica. 
 
Declaro que recebi, li e compreendi a explicação que me foi fornecida, por 
escrito e verbalmente, acerca da presente investigação e que me foram 
respondidas todas as questões que julguei necessárias. Nestas circunstâncias aceito 
participar neste projeto. 
 
Nome Completo: ________________________________________________ 
Assinatura: ______________________________________________________ 
___/___/_____ 
_______________________________________________ 
(Raquel Sofia Brandão de Carvalho) 
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Appendix II 
Declaração de consentimento informado 
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DECLARAÇÃO DE CONSENTIMENTO INFORMADO 
Titulo: Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
Eu, ________________________________________________________________ (nome 
completo), BI/CC nº: _____________ compreendi a explicação que me foi fornecida, 
por escrito e verbalmente, acerca da investigação que será conduzida pela 
Estudante Raquel Sofia Brandão de Carvalho da Faculdade de Medicina Dentária 
da Universidade do Porto, para qual é pedida a minha participação. Foi-me dada 
oportunidade de fazer as perguntas que julguei necessárias, e para todas obtive 
resposta satisfatória.  
Tomei conhecimento de que, de acordo com as recomendações da Declaração de 
Helsínquia, a informação que me foi prestada versou os objetivos, os métodos, os 
benefícios previstos, os riscos potenciais e o eventual desconforto. Além disso, foi-
me afirmado que tenho o direito de decidir livremente aceitar ou recusar a todo o 
tempo a minha participação no estudo. Sei que posso abandonar o estudo e que 
não terei que suportar qualquer penalização, nem quaisquer despesas pela 
participação neste estudo.  
Foi-me dado todo o tempo de que necessitei para refletir sobre esta proposta de 
participação.  
Nestas circunstâncias, consinto participar neste projeto de investigação, tal como 
me foi apresentado pela investigadora responsável sabendo que a 
confidencialidade dos participantes e dos dados a eles referentes se encontra 
assegurada.  
Mais autorizo que os dados deste estudo sejam utilizados para este e outros 
trabalhos científicos, desde que irreversivelmente anonimizados.  
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Data: ___/___/_____ 
 
 
Assinatura do paciente: 
___________________________________________________________________ 
 
O/A Investigador(a):  
___________________________________________________________________ 
Dados de contacto: raquelsbcarvalho@gmail.com 
 
O/A Orientador(a): 
___________________________________________________________________ 
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Questionário 
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Monografia de Investigação do Mestrado Integrado em Medicina Dentária 
Faculdade de Medicina Dentária da Universidade do Porto 
Ano Letivo: 2016/2017 
 
PROJETO DE INVESTIGAÇÃO 
 
 Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
QUESTIONÁRIO 
 
Caro(a) Participante: 
O presente questionário destina-se à recolha de dados para seleção de 
candidatos a participar num caso estudo sobre Hipersensibilidade Dentinária.  
Apresenta-se dividido em duas partes. A Parte I consiste num questionário 
dirigido à história clínica do paciente, sendo que a Parte II diz respeito ao exame 
clínico das peças dentárias envolvidas devendo ser preenchido pelo examinador 
clínico. 
A devida análise e conclusão do questionário terá uma duração aproximada 
de dez minutos, devendo ser preenchido nas consultas realizadas na clínica da 
FMDUP do corrente ano letivo. 
Obrigada pela participação. 
DENTIN HYPERSENSITIVITY MANAGEMENT 
A Clinical Study Investigating The Efficacy Of A Desensitizing Dentifrice  
 
 62 
Código do paciente: _______ 
Sexo: M ☐ F ☐ 
Idade: _____ 
Data: ______________ 
 
Parte I: História Clínica 
1. Está em tratamento médico? 
☐ Sim. Discriminar: _________________________________________________ 
☐ Não 
 
2. Toma alguma medicação? 
☐ Sim. Discriminar: _________________________________________________ 
☐ Não 
 
3. Tem alergias? 
☐ Sim. Discriminar: _________________________________________________ 
☐ Não 
 
4. Patologia Sistémica: 
☐ Cardiovascular: _________________________________________________ 
☐ Respiratória: ___________________________________________________ 
☐ Gastrointestinal: ________________________________________________ 
☐ Renal: ________________________________________________________ 
☐ Hematológica: __________________________________________________ 
☐ Imunológica: ___________________________________________________ 
☐ Nervosa: ______________________________________________________ 
☐ Endócrina e Metabólica: __________________________________________ 
☐ Óssea, Muscular e Articular: _______________________________________ 
☐ Genética: ______________________________________________________ 
☐ Infeciosa: ______________________________________________________ 
☐ Outra: _________________________________________________________ 
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5. Está grávida? 
☐ Sim. Nº de Meses: ________ 
☐ Não 
 
6. Hábitos Tabágicos 
☐ Nunca fumou 
☐ Fumador. Nº Cigarros/dia: ______ 
☐ Ex-Fumador 
 
7. Escova os dentes regularmente? 
☐ Sim. Quantas vezes: ______ 
☐ Não 
 
8. Tipo de escova: 
☐ Manual 
☐ Elétrica  
 
9. Qual é a dureza da sua escova de dentes? 
 ☐ Mole 
 ☐ Média 
 ☐ Dura 
 
10. Usa escovilhão e/ou fita/fio dentária?  
☐ Sim. Com que frequência? ________________________________________ 
☐ Não 
 
11. Realizou algum tratamento dentário recentemente? 
☐ Sim. Qual: _____________________________________________________ 
☐ Não 
 
12.  Apresenta/apresentou sintomas de sensibilidade dentária previamente a 
algum tratamento dentário? 
☐ Sim. Qual: _____________________________________________________ 
☐ Não 
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13.  Há quanto tempo apresenta sintomas de Hipersensibilidade Dentinária? 
________________________________________________________________ 
 
14.  Como classifica a intensidade de dor que sente/sentiu? 
□ Leve 
□ Moderada 
□ Elevada 
 
15.  Quando sente/sentiu Hipersensibilidade Dentinária? 
□ Nunca  
□ Às vezes 
□ Frequentemente 
□ Sempre 
 
16.  Já se sentiu impedido(a) de exercer alguma atividade devido à 
Hipersensibilidade Dentinária? 
□ Nunca 
□ Ocasionalmente 
□ Frequentemente 
□ Sempre 
 
17.  Sente/sentiu sensibilidade com: 
□ Frio 
□ Calor 
□ Escovagem 
□ Alimentos Ácidos 
□ Outros. Quais:__________________________________________________ 
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18.  Já visitou o Médico Dentista devido à Hipersensibilidade Dentinária? 
□ Sim 
□ Não 
 
19.  Fez ou está a fazer tratamento para a Hipersensibilidade Dentinária? 
□ Sim                               
□ Não                                 [Se não, prosseguir para Parte II] 
 
20.  Realiza/realizou tratamento onde? 
□ Casa                              
□ Consultório     
 
21.  Que forma de tratamento realizou? 
□ Dentífrico dessensibilizante   
□ Aplicação de Flúor (Tópica, Verniz, ...)                             
□ Restauração dentária                               
□ Tratamento Cirúrgico                                  
□ Laser 
□ Endodontia                               
□ Não sabe   
                     
22.  Durante o tratamento sentiu: 
□ Redução dos sintomas                               
□ Eliminação dos sintomas 
□ Não sentiu alterações  
 
23.  Após o tratamento sentiu: 
□ Redução dos sintomas                               
□ Eliminação dos sintomas 
□ Não sentiu alterações                                                            
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Parte II: Exame Clínico  
 
1. Quais os dentes afetados pela Hipersensibilidade Dentinária? 
___________________________________________________________ 
 
2. Indique o número total de dentes afetados: 
___________________________________________________________ 
 
3. O(s) dente(s) afetado(s) foram submetidos a algum tratamento? 
☐ Sim. Qual? Foi usado algum material restaurador?  
________________________________________________________________________ 
☐ Não 
 
4. O(s) dente(s) afetado(s) apresentam recessão gengival? 
☐ Sim  
☐ Não 
 
 
 
Obrigada pela colaboração! 
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Appendix IV 
Avaliação pós-utilização  
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Monografia de Investigação do Mestrado Integrado em Medicina Dentária 
Faculdade de Medicina Dentária da Universidade do Porto  
Ano Letivo: 2016/2017 
 
PROJETO DE INVESTIGAÇÃO 
 
Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
AVALIAÇÃO DA HIPERSENSIBILIDADE DENTINÁRIA 
 
 
 
 
 
Instruções:  
Por favor indique o seu nível de dor provocado por hipersensibilidade 
dentinária, assinalando na escala o que melhor representa o seu estado atual.  
Obrigada pela sua participação. 
1. Grau de dor 
Identificação do Participante 
Nº________ 
Data: ___/___/_____ 
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2. Duração da dor 
 
 
 
 
 
3. Intensidade da dor 
 
 
 
 
 
4. Tolerância à dor 
 
 
 
 
 
5. Descrição da dor 
 
 
  
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderad
a 
Severa Incapacitante 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Instantânea Média 
duração 
Prolongada Persistente 
0      1      2      3      4      5      6      7      8      9      10 
Ausente 
Pouco 
Perceptível  
Dor 
incômoda Severa 
Aguda 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Pontada Aflitiva Latejante Excruciante 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Tolerável Desconfortável Debilitante Insuportável 
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Appendix V 
Avaliação de Hipersensibilidade (air-blast e thermal) 
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Monografia de Investigação do Mestrado Integrado em Medicina Dentária 
Faculdade de Medicina Dentária da Universidade do Porto  
Ano Letivo: 2016/2017 
 
PROJETO DE INVESTIGAÇÃO 
 
Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
AVALIAÇÃO DA HIPERSENSIBILIDADE DENTINÁRIA 
 
 
 
 
 
Instruções:  
Por favor indique o seu nível de dor provocado por hipersensibilidade 
dentinária, assinalando na escala o que melhor representa o seu estado atual.  
Obrigada pela sua participação. 
 
Pre-application 
Identificação do Participante 
Nº___ 
Data: ___/___/_____ 
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Air-Blast Assessment:  
 
 
Teeth Score Teeth  Score 
 
 
 
 
 
 
 
   
 
Thermal Assessment: 
Teeth Score Teeth  Score 
 
 
 
 
 
 
 
   
 
Efeitos Colaterais? 
□ Sim. Discriminar: _________________________________________________ 
□ Não  
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderad
a 
Severa Intolerável 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderad
a 
Severa Intolerável 
 0       1       2       3       
Schiff Assessment 
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Post-application 
 
Air-Blast Assessment:  
 
 
Teeth Score Teeth  Score 
 
 
 
 
 
 
 
   
 
Thermal Assessment: 
Teeth Score Teeth  Score 
 
 
 
 
 
 
 
   
 
Efeitos Colaterais? 
□ Sim. Discriminar: _________________________________________________ 
□ Não 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderad
a 
Severa Intolerável 
0      1      2      3      4      5      6      7      8      9      10 
Ausente Leve Moderad
a 
Severa Intolerável 
 0       1       2       3       
Schiff Assessment 
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Appendix VI 
Cuidados a ter 
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Monografia de Investigac ̧a ̃o do Mestrado Integrado em Medicina Denta ́ria 
Faculdade de Medicina Denta ́ria da Universidade do Porto  
Ano Letivo: 2016/2017 
 
PROJETO DE INVESTIGAÇÃO 
 
Controlo da Hipersensibilidade Dentinária: Estudo clínico a 
investigar a eficácia de um dentífrico dessensibilizante 
 
CUIDADOS A TER 
 
 Após a aplicação do produto: 
• Não deve comer ou beber durante 30 minutos após o procedimento; 
• Evitar bebidas quentes, produtos que contenham álcool (ex. vinho), 
comida dura ou pegajosa pelo menos durante 4 horas após o 
procedimento. 
 
Nos dias de avaliação (Follow-up): 
• Deve abster-se de mastigar chiclete durante 8 horas, e comer e beber 
durante 4 horas; 
• Deve abster-se de utilizar colutórios/elixires como meios auxiliares de 
higiene durante o curso da investigação; 
• Não existem outras restrições de dieta ou hábitos tabágicos. 
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Appendix VII 
Parecer da Comissão de Ética 
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Appendix VIII 
Declaração de Autoria 
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Declaração 
 
Monografia de Investigação/Relatório de Atividade Clínica 
 
 
Declaro que o presente trabalho, no âmbito da Monografia de 
Investigação/Relatório de Atividade Clínica, integrado no MIMD, da FMDUP, 
é da minha autoria e todas as fonte foram devidamente referenciadas. 
 
 
 
Porto, 7 de Julho de 2017 
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Appendix IX 
Parecer do Orientador 
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